Unknown

Dataset Information

0

Efficacy and Safety of Native and Recombinant Zona Pellucida Immunocontraceptive Vaccines Formulated with Non-Freund's Adjuvants in Donkeys.


ABSTRACT: This study aimed to test zona pellucida (ZP) vaccines’ immunocontraceptive efficacy and safety when formulated with non-Freund’s adjuvant (6% Pet Gel A and 500 Μg Poly(I:C)). Twenty-four jennies were randomly assigned to three treatment groups: reZP (n = 7) received three doses of recombinant ZP vaccine; pZP (n = 9) received two doses of native porcine ZP; and Control group (n = 8) received two injections of placebo. Jennies were monitored weekly via transrectal ultrasonography and blood sampling for serum progesterone profiles and anti-pZP antibody titres. In addition, adverse effects were inspected after vaccination. Thirty-five days after the last treatment, jacks were introduced to each group and rotated every 28 days. Vaccination with both pZP and reZP was associated with ovarian shutdown in 44% (4/9) and 71% (4/7) of jennies, 118 ± 33 and 91 ± 20 days after vaccination, respectively (p > 0.05). Vaccination delayed the chances of a jenny becoming pregnant (p = 0.0005; Control, 78 ± 31 days; pZP, 218 ± 69 days; reZP, 244 ± 104 days). Anti-pZP antibody titres were elevated in all vaccinated jennies compared to Control jennies (p < 0.05). In addition, only mild local injection site reactions were observed in the jennies after treatment. In conclusion, ZP vaccines formulated with non-Freund’s adjuvant effectively controlled reproduction in jennies with only minor localised side effects.

SUBMITTER: French H 

PROVIDER: S-EPMC9788400 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Efficacy and Safety of Native and Recombinant Zona Pellucida Immunocontraceptive Vaccines Formulated with Non-Freund's Adjuvants in Donkeys.

French Hilari H   Segabinazzi Lorenzo L   Middlebrooks Brittany B   Peterson Erik E   Schulman Martin M   Roth Robyn R   Crampton Michael M   Conan Anne A   Marchi Silvia S   Gilbert Trevor T   Knobel Darryn D   Bertschinger Henk H  

Vaccines 20221124 12


This study aimed to test zona pellucida (ZP) vaccines’ immunocontraceptive efficacy and safety when formulated with non-Freund’s adjuvant (6% Pet Gel A and 500 Μg Poly(I:C)). Twenty-four jennies were randomly assigned to three treatment groups: reZP (n = 7) received three doses of recombinant ZP vaccine; pZP (n = 9) received two doses of native porcine ZP; and Control group (n = 8) received two injections of placebo. Jennies were monitored weekly via transrectal ultrasonography and blood samplin  ...[more]

Similar Datasets

| S-EPMC8668373 | biostudies-literature
| S-EPMC2528931 | biostudies-literature
| S-EPMC7737619 | biostudies-literature
| S-EPMC3772061 | biostudies-literature
| S-EPMC4936747 | biostudies-literature
| S-EPMC6297288 | biostudies-literature
| S-EPMC8005149 | biostudies-literature
| S-EPMC4456372 | biostudies-literature
| S-EPMC8621233 | biostudies-literature
| S-EPMC6884566 | biostudies-literature